Hansoh Pharmaceutical Group Co., Ltd. (3KY)
FSX
Real-time Data
06:00 AM
Day's Range
3.6852 wk Range
3.09Overview - 3KY - Hansoh Pharmaceutical Group Co., Ltd.
Key Statistics
Valuation
Enterprise Value
-1.49B
P/E (Trailing)
‪29.52‬
Price / Sales (TTM)
‪1.35‬
Price / Book
‪4.43‬
EV / EBITDA
‪-1.85‬
Profitability
Profit Margin
‪42.00%‬
Operating Margin
‪44.37%‬
Return on Assets
‪9.08%‬
Return on Equity
‪19.39%‬
Ownership
Shares Outstanding
6.05B
Float
1.23B
Held by Insiders
‪79.55%‬
Held by Institutions
‪12.28%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪3.63‬
200-Day Avg
‪3.81‬
Dividends
Payout Ratio
‪36.07%‬
Frequency
Semi-Annual
Market Cap - 3KY - Hansoh Pharmaceutical Group Co., Ltd.
Peers - 3KY - Hansoh Pharmaceutical Group Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - 3KY - Hansoh Pharmaceutical Group Co., Ltd.
About
Hansoh Pharmaceutical Group Co., Ltd. is a leading biopharmaceutical company that primarily specializes in the research, development, manufacturing, and sale of innovative therapeutics. The company focuses on addressing unmet medical needs in areas such as oncology, central nervous system disorders, anti-diabetes, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
